S-777469

DB16321InvestigationalSmall molecule

S-777469 is under investigation in clinical trial NCT00703573 (A Randomized, Double-blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis).

Mechanism: Pharmacologically active on Cannabinoid receptor 2
Curator reviewed
Formula / weight: C₂₃H₂₇FN₂O₄ · 414.477 g/mol (avg)
Code names: S-777469

Resolves to

Compound

UNII88NI79737ICAS885496-53-7ChEMBLCHEMBL2019090

Structure

InChIKeyJIYXOJFSPOFZPY-UHFFFAOYSA-NSMILESCCC1=C(C)C=C(C(=O)NC2(CCCCC2)C(O)=O)C(=O)N1CC1=CC=C(F)C=C1

Targets

P34972CNR2

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with S-777469, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account